Navigation Links
EyeCRO Receives Full Accreditation from AAALAC International for its Research Facilities
Date:3/14/2019

EyeCRO LLC has been awarded full accreditation from AAALAC International for their facility in Oklahoma City, OK. EyeCRO joins the Department of Veterans Affairs, the Oklahoma Medical Research Foundation, Oklahoma State University, and the University of Oklahoma Health Sciences Center as the fifth institution in Oklahoma to receive this prestigious endorsement. The award letter from AAALAC International stated: “Especially noteworthy were the strong administrative commitment to the program; the top-down commitment to a culture of care; the well written Program Description addressing all required elements; the well maintained and clean facilities; the thorough and well documented staff training; and the excellent veterinary medical care.”

“We are excited to join the select group of AAALAC-accredited institutions. There are approximately 1000 institutions that have achieved this level of excellence worldwide and we are proud to accomplish this within one year after opening our new research facility,” said Dr. Eric Phelps, Director of Research and Development.

“Our team is excited to receive this tremendous honor that recognizes our commitment to strong science and the highest standards of preclinical research,” said Alexander Quiambao, Vice President of Operations. “This enhances our ability to assist companies around the world which are advancing vision-saving therapies that can treat various forms of blindness,” said Quiambao.

EyeCRO has also recently finished construction of a state-of-the-art addition to its facility for conducting good laboratory practice (GLP) preclinical studies. “This addition will allow us to provide services covering the full-range of preclinical ophthalmic drug development, from performing initial proof-of-concept pharmacology studies to conducting important toxicology and pharmacokinetic studies required by the FDA to enable human clinical trials,” said Dr. Rafal Farjo, Chief Executive Officer.

About EyeCRO
EyeCRO is the global leader in the performance of preclinical ophthalmic research to advance therapeutic discovery and development programs. The company operates laboratories in Oklahoma City, OK and Ann Arbor, MI which provide validated contract research services to the ophthalmic research community worldwide. These include studies in a number of well-established models to accurately evaluate the activity and pharmacokinetics of test agents for treating diseases such as Wet and Dry Age-Related Macular Degeneration, Diabetic Retinopathy, Retinitis Pigmentosa, Leber's Congenital Amaurosis, Glaucoma, Dry Eye Disease, Conjunctivitis, and Uveitis. In addition, the company offers formulation services for eyedrop delivery of lipophilic small molecules using the innovative and patented MiDROPS™ platform. EyeCRO is currently advancing an internal program utilizing this technology with Cyclosporin-A-MiDROPS™ for the once-daily treatment of Dry Eye Disease and expects to begin clinical trials by the first quarter of 2020. For more information, see http://www.EyeCRO.com

Read the full story at https://www.prweb.com/releases/eyecro_receives_full_accreditation_from_aaalac_international_for_its_research_facilities/prweb16164437.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. EyeCRO and MPI Research Partner to Develop New Preclinical Models of Ophthalmic Disease
2. Lyncean Technologies, Inc. receives $1.1M grant from DOE to develop the Compact Light Source
3. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
4. DiaCarta Inc. Receives CE Mark for QuantiVirus® HPV E6/E7 mRNA Assay
5. Physicians for Peace Receives Logo Embroidered Lab Coat Donation from Crooked Brook
6. APPLIED PHYSIOLOGY® Receives key US Patent Award for its Unique NAVIGATOR™ Technology
7. Iowa Educator Receives DuPont AgriSCIENCE Award for Teaching Excellence
8. Spinifex Receives $1.5m in R&D Tax Incentive for Research Activities Related to the Discovery of Treatments for Pain
9. Physicians for Peace Resource Mothers Program Receives Fleece Blanket Donation
10. Entia Receives Notices of Allowance for its Ergothioneine and Genetic Transporter Patents from the United States, Canada, and Israel
11. Physicians for Peace Receives Logo Embroidered Polo Shirt Donation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/6/2019)... ... 2019 , ... Advanced Clinical, a clinical research services organization, ... PharmaVOICE magazine, earning him a prestigious spot on the 2019 PharmaVOICE 100 list. ... As the executive vice president of business development and marketing at Advanced Clinical, ...
(Date:7/26/2019)... BOSTON (PRWEB) , ... July 25, 2019 , ... ... senior-level biopharma leaders through off-the-record collaboration and dialogue, today announces its Boston ... Boston Waterfront Hotel. As part of Biotech Week Boston , the event ...
(Date:7/17/2019)... ... 15, 2019 , ... CRISPR is often thought of as “molecular scissors” used ... replaced, or edited, but Yiping Qi, assistant professor in Plant Science & Landscape Architecture ... latest publication in Nature Plants. In this comprehensive review, Qi and coauthors in his ...
(Date:7/9/2019)... ... July 08, 2019 , ... Today, at the BIO World Congress ... Growers Association (NCGA) announced the winners of the Consider Corn Challenge II. Three ... using field corn to produce biobased materials. , “Corn is a sustainable, abundant ...
Breaking Biology Technology:
(Date:8/4/2019)... ... ... Stay on top of current hot topics through free webinars presented by leading experts ... so be sure to register today to save your place! Participate in the discussion ... upcoming webinars: , CLINICAL OPERATIONS , August 27 – Friend or Foe? An Assessment ...
(Date:8/1/2019)... , ... July 30, 2019 , ... ... as the George B. and Joy Rathmann Professor in Bioprocessing and Director of ... innovative leader in the life sciences industry and possesses more than 25 years ...
(Date:7/26/2019)... ... 2019 , ... Worldwide Business with kathy ireland® ... Deschamps to discuss their potential new treatment option to manage neurological symptoms of ... in the medical device industry that's focused on neurological wellness. With a sharp ...
Breaking Biology News(10 mins):